(Alliance News) - AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in the US. The Cambridge, England-based biopharmaceutical company ...
It is a pivotal step forward in strengthening our market position, as a leading producer of mineral sands, and delivering greater value to our shareholders. I look forward to updating shareholders on ...